药学学报, 2018, 53(4): 621-629
引用本文:
葛璐, 邱立朋, 单晓甜, 毛静, 李志超, 陈敬华. Heparosan多糖聚合物胶束的制备及体外抗肿瘤活性[J]. 药学学报, 2018, 53(4): 621-629.
GE Lu, QIU Li-peng, SHAN Xiao-tian, MAO Jing, LI Zhi-chao, CHEN Jing-hua. Preparation and properties of heparosan polysaccharide-vitamin E succinate polymer micelles[J]. Acta Pharmaceutica Sinica, 2018, 53(4): 621-629.

Heparosan多糖聚合物胶束的制备及体外抗肿瘤活性
葛璐, 邱立朋, 单晓甜, 毛静, 李志超, 陈敬华
江南大学药学院, 江苏 无锡 214122
摘要:
聚合物胶束作为新型药物传递系统可以提高疏水性药物的溶解性并具有良好的生物相容性和稳定性。本研究通过合成heparosan多糖-维生素E琥珀酸酯(heparosan-adipic dihydrazide-vitamin E succinate,KV)载体,利用核磁共振氢谱(1H NMR)对其进行结构确证。以疏水性抗肿瘤药多柔比星(doxorubicin,DOX)为模型药物,制备载DOX的KV聚合物胶束(DOX/KV),并对其进行表征。结果表明,胶束形貌为球形,粒径为140~150 nm,zeta电位为-20 mV左右,包封率为80%左右,载药量在10%~15%之间,并且具有良好的缓释行为。选择MGC80-3肿瘤细胞和COS7正常细胞考察体外细胞毒性和细胞摄取情况。体外细胞毒性结果显示,空白胶束对两种细胞几乎没有毒性,载药胶束对MGC80-3细胞的细胞毒性要大于COS7细胞。从细胞摄取考察也可以看出,载药胶束对MGC80-3细胞的摄取量更高。综上,KV可以很好地包载DOX,并且可以提高其对癌细胞的选择性,具有良好的抗肿瘤活性。
关键词:    Heparosan多糖      维生素E琥珀酸酯      聚合物胶束      多柔比星     
Preparation and properties of heparosan polysaccharide-vitamin E succinate polymer micelles
GE Lu, QIU Li-peng, SHAN Xiao-tian, MAO Jing, LI Zhi-chao, CHEN Jing-hua
School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, China
Abstract:
Due to the advantages of polymer micelles and the anticancer activity of doxorubicin (DOX), the polymer micelle of DOX is expected to be used for drug delivery in anticancer applications. As a biocompatible and biodegradable polymer, amphiphilic copolymer heparosan-adipic dihydrazide-vitamin E succinate (KV) can be self-assembled to form micelles with core-shell structure in aqueous phase. In this article, KV conjugates with two different degrees of substitution (DS) were synthesized to load DOX and were characterized by 1H NMR. The size distribution, morphology, zeta potential and release behavior in vitro of the DOX-loaded micelles were studied. In vitro cytotoxicity was investigated by MTT assay against MGC80-3 and COS7 cells. The cellular uptake of the DOX-loaded micelles was observed by fluorescence microscopy and flow cytometry. The 1H NMR spectra results confirmed the KV polymers were successfully conjugated and the degree of VES grafted on heparosan polysaccharide were 12% and 25%. Briefly, the micelles with two different DS were expressed as KV12 and KV25. The DOX-loaded micelles could resist serum adsorption because of the negative charge on the surface. The average particle size measured by dynamic light scattering (DLS) method was 140-150 nm and the TEM results indicated that the morphology of DOX-loaded micelles were spherical. The encapsulation efficiency and drug loading were 80% and 10%-15%, respectively. The DOX-loaded micelles had sustained release behavior and the cumulative release of DOX/KV12 was slightly higher than DOX/KV25. Moreover, the viabilities of cells which were co-incubated with blank micelles were greater than 90%. It is clear that the blank micelles almost non-toxic to both cells. The IC50 of drug-loaded micelles against COS7 cells was much higher than that of MGC80-3 cells and the DOX/KV12 exhibited greater cytotoxicity. The cellular uptake of DOX/KV on MGC80-3 was greater than COS7 cells. In this study, KV polymer micelles have a sustained drug release activity and have a good selectivity to tumor cells, so it would be a potential carrier in drug delivery.
Key words:    heparosan polysaccharide    vitamin E succinate    polymer micelles    doxorubicin   
收稿日期: 2017-11-03
DOI: 10.16438/j.0513-4870.2017-1083
基金项目: 国家自然科学基金资助项目(81503007).
通讯作者: 陈敬华,Tel:86-13-861704096,E-mail:chenjinghua@jiangnan.edu.cn
Email: chenjinghua@jiangnan.edu.cn
相关功能
PDF(543KB) Free
打印本文
0
作者相关文章
葛璐  在本刊中的所有文章
邱立朋  在本刊中的所有文章
单晓甜  在本刊中的所有文章
毛静  在本刊中的所有文章
李志超  在本刊中的所有文章
陈敬华  在本刊中的所有文章

参考文献:
[1] Huan ML, Zhou SY, Teng ZH, et al. Conjugation with α-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin[J]. Bioorg Med Chem Lett, 2009, 19:2579-2584.
[2] Zhang D, Li JY, Wang XC, et al. Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly (2-ethyl-2-oxazoline)-cholesteryl methyl carbonate[J]. Acta Pharm Sin (药学学报) 2015, 50:1174-1179.
[3] Jia N, Ye Y, Wang Q, et al. Preparation and evaluation of poly(L-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells[J]. Asian J Pharm Sci, 2017, 12, 433-441.
[4] Peer D, Karp JM, Hong SP, et al. Nanocarriers as an emerging platform for cancer therapy[J]. Nat nanotechnol, 2007, 2:751-760.
[5] Danhier F, Feron O, Préat V. To exploit the tumor microen-vironment:passive and active tumor targeting of nanocarriers for anti-cancer drug delivery[J]. J Control Release, 2010, 148:135-146.
[6] Hu Y, He X, Lei L, et al. Preparation and characterization of self-assembled nanoparticles of the novel carboxymethyl pachyman-deoxycholic acid conjugates[J]. Carbohydr Polym, 2008, 74:220-227.
[7] Yin XL, Zhang B, Liu YJ, et al. Advances in polymer-drug conjugated micelles in the delivery of anticancer drugs[J]. Acta Pharm Sin (药学学报), 2016, 51:710-716.
[8] Hehir S, Cameron NR. Recent advances in drug delivery systems based on polypeptides prepared from N-carboxyan-hydrides[J]. Polym Int, 2014, 63:943-954.
[9] Li R, Song XN, Zhang H, et al. The integrity study on PEG-PCL micelles transcellular transported across MDCK epithelial cell monolayer using FRET technology[J]. Acta Pharm Sin (药学学报), 2016, 51:1316-1324.
[10] Mao SR, Tian Y, Wang LL. Research progress on drug nano-container-polymeric micelles[J]. J Shenyang Pharm Univ (沈阳药科大学学报), 2010, 27:979-986.
[11] Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems[J]. Asian J Pharm Sci, 2015, 10:81-98.
[12] Zhang Y, Feng J, Jia Y, et al. Development of tetrahydroiso-quinoline-based hydroxamic acid derivatives:potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities[J]. J Med Chem, 2011, 54:2823-2838.
[13] Gao HL, Jiang XG. The development of novel tumor targeting delivery strategy[J]. Acta Pharm Sin (药学学报), 2016, 51:272-280.
[14] Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy:an overview[J]. Asian J Pharm Sci, 2016, 11:337-348.
[15] Richter AW, Åkerblom E. Polyethylene glycol reactive antibodies in man:titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors[J]. Int Arch All Immunol, 1984, 74:36-39.
[16] Rong L, Zhang YT, Hu QH. Progress in the research of natural polymer micelle[J]. Chin J Mod Appl Pharm (中国现代应用药学), 2010, 27:1182-1187.
[17] Baldwin AD, Kiick KL. Polysaccharide-modified synthetic polymeric biomaterials[J]. Biopolymers, 2010, 94:128-140.
[18] Zhao L, Yan ZQ, Wang C. Progress of study on the heparoson production by E.coli K5[J]. Curr Biotechnol (生物技术进展), 2011, 1:195-200.
[19] Wang XY, Song HJ. Biosynthesis pathway and structure variability of bacterial endotoxin[J]. J Food Sci Biotechnol (食品与生物技术学报), 2013, 32:1009-1015.
[20] Raman K, Mencio C, Desai UR, et al. Sulfation patterns determine cellular internalization of heparin-like polysaccharides[J]. Mol Pharm, 2013, 10:1442-1449.
[21] Capila I, Linhardt RJ. Heparin-protein interactions[J]. Angew Chem Int Ed Engl, 2002, 41:391-412.
[22] Barzu T, Van Rijn J, Petitou M, et al. Heparin degradation in the endothelial cells[J]. Thromb Res, 1987, 47:601-609.
[23] DeAngelis PL. HEPtune:a process of conjugating a naturally occurring sugar molecule, heparosan, to a drug for enhanced drug delivery[J]. Drug, 2013, 13:34-38.
[24] Grinda M, Clarhaut J, Renoux B, et al. A self-immolative dendritic glucuronide prodrug of doxorubicin[J]. Med Chem Commun, 2012, 3:68-70.
[25] Blundell CD, Roberts IS, Sheehan JK, et al. Investigating the molecular basis for the virulence of Escherichia coli K5 by nuclear magnetic resonance analysis of the capsule polysaccharide[J]. J Mol Microbiol Biotechnol, 2009, 17:71-82.
[26] You H, Yu W, Munoz-Medellin D, et al. Role of extracellular signal-regulated kinase pathway in RRR-α-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells[J]. Mol Carcinog, 2002, 33:228-236.
[27] Gu X, Song X, Dong Y, et al. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo[J]. Clin Cancer Res, 2008, 14:1840-1848.
[28] Ni J, Chen M, Zhang Y, et al. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery[J]. Biochem Biophys Res Commun, 2003, 300:357-363.
[29] Bao Y, Yin M, Hu X, et al. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery[J]. J Control Release, 2016, 235:182-194.
[30] Peng Y, Zhao J, Hou L, et al. Vitamin E succinate induces apoptosis via the PI3K/AKT signaling pathways in EC109 esophageal cancer cells[J]. Mol Med Rep, 2016, 14:1531-1537.
[31] Neuzil J, Dong LF, Ramanathapuram L, et al. Vitamin E analogues as a novel group of mitocans:anti-cancer agents that act by targeting mitochondria[J]. Mol Aspects Med, 2007, 28:607-645.
[32] Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer[J]. J Control Release, 2001, 70:63-70.
[33] Du JZ, Tang LY, Song WJ, et al. Evaluation of polymeric micelles from brush polymer with poly(ε-caprolactone)-b-poly (ethylene glycol) side chains as drug carrier[J]. Biomacro-molecules, 2009, 10:2169-2174.
[34] Lo CL, Huang CK, Lin KM, et al. Mixed micelles formed from graft and diblock copolymers for application in intracel-lular drug delivery[J]. Biomaterials, 2007, 28:1225-1235.
[35] Huang Q, Li Y, Zhang H, et al. Environmental-responsive behavior of poly(acrylic acid)[J]. Acta Chim Sin (化学学报), 2009, 67:2421-2426.
[36] Xiao L, Xiong X, Sun X, et al. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles[J]. Biomaterials, 2011, 32:5148-5157.
[37] Peng HH, Li Y, Yuan JY, et al. Endocytosis pathway and intracellular distribution of heparosan[J]. Acta Pharm Sin (药学学报), 2017, 52:474-480.
相关文献:
1.许向阳;周建平;李玲;张勇;霍美蓉;王星;吕霖.多柔比星壳聚糖聚合物胶束的制备及其在小鼠体内的组织分布[J]. 药学学报, 2008,43(7): 743-748